Justin M. Hall
Justin M. Hall
Send Message
Justin M. Hall
Stop FollowingJustin M. Hall
View as an RSS Feed
- Bank Of America Well Positioned For A Big Move (Follow-Up)
- Bank Of America Potentially Setting Up For Big Move
- New Kids' Tablet Should Help LeapFrog Jump Higher
- The Big Move: The End Of The 2011 Corn Bubble Nears
- The Big Move (Part 3): The 2011 Corn Bubble Will Burst
- The Big Move (Part 2): Playing The Corn Bubble With These 2 ETFs
- The Big Move (Part 1): The Corn Correction Of 2011
- Strategies for Pending Biotech Correction
- Biotech Stock ETF Due for a Correction
- Teva Positioned to Acquire Spectrum Pharmaceuticals?
- Look for Spectrum Pharmaceuticals to Rebound Short-Term
- Teva Positioned to Acquire Spectrum Pharmaceuticals After Fusilev Approval
- Spectrum Pharmaceuticals Set to Beat Analyst Estimates Today
- FDA Likely to Approve Spectrum Pharma's Cancer Drug After Second Look
- Spectrum Pharma: Zevalin Has Blockbuster Potential 2.0
- Optimistic About Endologix Following Nellix Acquisition
- EpiCept's Promising Leukemia Drug: A Buying Opportunity?
- Spectrum Pharmaceuticals: Packed With Opportunities
- Three Promising Small-Cap Cancer Plays
- Anika: A Hidden Biotech Buy
- Spectrum Pharmaceuticals: Looking Ahead at Continued Growth
- Infinity Pharmaceuticals: A Promising, Underappreciated Cancer Drug Maker
- Three Underappreciated Cancer Drug Makers
- Spectrum Pharma: Additional Trial Not Required
- December's Game Plan for Biotech
- Spectrum Pharma: Zevalin Sales Ramp Up
- Spectrum Pharma: CMS Rules in Favor of Zevalin
- Spectrum Pharma: Zevalin Has Blockbuster Potential
- On Small Cap Drug Makers and Volatility
- Spectrum Pharmaceuticals: Undervalued and (Now) Oversold
- How Zevalin Is Helping Spectrum
- Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
